Atlas Trials

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

Clinical trial NCT05860374 · UNKNOWN

Trial details

NCT number
NCT05860374
Sponsor
Shanghai Yunying Medical Technology
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
SarcomaCarcinomaBreast CancerPancreatic CancerColorectal CancerGastric CancerLiver CancerLung CancerGynecologic Cancer
Start date
2023-03-02
Primary completion
2025-03-02
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.